Side Effects Of Actos And Bringing A Claim
Actos, a prescription pill for diabetes known as pioglitazone, was introduced to the market in the late 1990s. It belongs to a class of drugs called thiazolidinediones that lower blood glucose levels and therefore raise the body’s sensitivity to insulin. This reduction in blood glucose levels is vital for people suffering from Type-2 diabetes. Actos has been prescribed to millions of diabetic patients suffering from Type-2 diabetes as a solution and an aid in living normal lives. Recent studies, however, have shown that the use of Actos may have devastating and life-threatening side effects such bladder cancer, heart attacks, anemia, myalgia and more.
FDA Requires Warnings Regarding Risks Posed By Actos
The U.S. Food and Drug Administration (FDA) has issued a statement requiring the manufacturers of this drug to immediately include a black box warning on every Actos package. In addition, the FDA has further released alerts to warn patients of the dangers and side effects associated with the use of Actos.
Presently, there are hundreds, if not thousands, of pending lawsuits by innocent victims of the side effects caused by the use of the Actos drug on which they relied to ensure prolonged living. Every day, another innocent person falls victim to the side effects of Actos.
Millions Recovered For Our Clients
If you have been prescribed Actos and are experiencing negative side effects, you may be entitled to compensation for medical expenses and pain and suffering. Paris & Chaikin, PLLC, is a law firm specializing in the pursuit of justice. Our goal is to ensure that innocent victims of the wrongdoings of large corporations are compensated for the pain and injuries they sustain. Our record of positive results for our clients has earned us recognition, such as being named as members of the Million Dollar Advocates Forum and Multi-Million Dollar Advocates Forum.
The defective drug lawyers at Paris & Chaikin, PLLC, want to help! Contact us today at 212-742-0476 for a free lawsuit evaluation.